Research
Hormonal
GLP-1 receptor agonists (e.g., semaglutide, tirzepatide) induce substantial weight loss (up to 20%) by acting on CNS neural circuits, specifically the dorsal vagal complex.
GLP-1 medications like semaglutide and tirzepatide are highly effective for weight loss, often resulting in 10-20% body weight reduction. They work by acting on brain circuits that control appetite. You must take them chronically, as stopping leads to weight regain. Side effects like nausea are common but manageable.
StrongSupportsVERY_HIGH confidence
Higher doses of semaglutide (sold as Wegovy) resulted in >10% placebo-corrected weight loss... a recent report has shown that an ablation of neurons in the dorsal vagal complex (DVC)... markedly attenuate the anorectic effect of semaglutide and exendin-4.
Why this rating
Supported by multiple clinical trials and mechanistic studies cited.
Source
On the causes of obesity and its treatment: The end of the beginning
Jeffrey M. Friedman · Cell Metabolism · 2025
narrative_reviewCited 21×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →